( en | de | ru )

 

Disambiguation of "Granoff, Dan M."

Author of the publication

copydeleteadd this publication to your clipboard
Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates

, , , and . Vaccine, 28 (9): 2122--2129 (February 2010)
DOI: 10.1016/j.vaccine.2009.12.027

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Dan Stern

Horst Dan

Dan Radulescu

Dan Rusdea

Dan Wang

 

Other publications of authors with the same name

Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. Vaccine, (June 2009)PMID: 19477054.Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870, , and . Vaccine, 25 (10): 1912--20 (February 2007)PMID: 16677743.Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor h-binding protein and genetically attenuated endotoxin, , and . The Journal of Infectious Diseases, 198 (2): 262--70 (July 2008)PMID: 18505380.Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine, , , and . Infection and Immunity, 71 (1): 275--286 (January 2003)PMID: 12496177.Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates, , , and . Vaccine, 28 (9): 2122--2129 (February 2010)Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity, , and . Clinical and Vaccine Immunology: CVI, 16 (6): 785--791 (June 2009)PMID: 19339487.The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance, , , , , , , , , and . Journal of Immunology (Baltimore, Md.: 1950), 177 (1): 501--510 (July 2006)PMID: 16785547.